MRSA Research Today is a free monthly online journal that collates and summarizes the latest research about MRSA, including details on methicillin-resistant staphylococcus aureus, hospitals, infection, antibiotic resistance, superbugs.

Volume 5 (2008), Issue 2 (February)

1. An effective computerized reminder for contact isolation of patients colonized or infected with resistant organisms.
   Int J Med Inform, 77(3): 194-8. [Abstract] [Full-text]
2. Antibacterial activity of plants used in traditional medicines of Ghana with particular reference to MRSA.
   J Ethnopharmacol, 116(1): 102-11. [Abstract] [Full-text]
3. Fluoroquinolone therapy in a rabbit model of post-LASIK methicillin-resistant Staphylococcus aureus keratitis.
   J Cataract Refract Surg, 34(2): 295-301. [Abstract] [Full-text]
4. A pilot study to investigate patients reported knowledge, awareness, and beliefs on health care-associated infection.
   Am J Infect Control, 36(1): 63-9. [Abstract] [Full-text]
5. Influenza-like illness in residential care homes: A study of the incidence, aetiological agents, natural history, and health resource utilization.
   Thorax. [Abstract] [Full-text]
6. Glomerulonephritis causing acute renal failure during the course of bacterial infections. Histological varieties, potential pathogenetic pathways and treatment.
   Int Urol Nephrol. [Abstract] [Full-text]
7. The Modified APACHE II score outperforms Curb65 pneumonia severity score as a predictor of 30-day mortality in patients with methicillin-resistant Staphylococcus aureus pneumonia.
   Chest, 133(2): 363-9. [Abstract] [Full-text]
8. Methicillin-resistant Staphylococcus aureus nasal carriage among injection drug users: six years later.
   J Clin Microbiol, 46(2): 477-9. [Abstract] [Full-text]
9. Genotypic characteristics of Staphylococcus aureus isolates from a multinational trial of complicated skin and skin structure infections.
   J Clin Microbiol, 46(2): 678-84. [Abstract] [Full-text]
10. Prediction of methicillin-resistant Staphylococcus aureus involvement in disease sites by concomitant nasal sampling.
    J Clin Microbiol, 46(2): 588-92. [Abstract] [Full-text]
11. Comparison of the BD GeneOhm methicillin-resistant Staphylococcus aureus (MRSA) PCR assay to culture by use of BBL CHROMagar MRSA for detection of MRSA in nasal surveillance cultures from an at-risk community population.
    J Clin Microbiol, 46(2): 743-6. [Abstract] [Full-text]
12. Infection control strategies for preventing the transmission of meticillin-resistant Staphylococcus aureus (MRSA) in nursing homes for older people.
    Cochrane Database Syst Rev. [Abstract] [Full-text]
13. Dalbavancin and telavancin: novel lipoglycopeptides for the treatment of Gram-positive infections.
    Expert Rev Anti Infect Ther, 6(1): 67-81. [Abstract] [Full-text]
14. Is antimicrobial therapy needed to manage uncomplicated skin and soft-tissue abscesses?
    Expert Rev Anti Infect Ther, 6(1): 9-13. [Abstract] [Full-text]
15. MRSA in Austria--an overview.
    Clin Microbiol Infect, 14(3): 250-9. [Abstract] [Full-text]
16. Occult methicillin-resistant Staphylococcus aureus abscesses in 2 pediatric patients.
    Clin Pediatr (Phila), 47(2): 176-9. [Abstract] [Full-text]
17. Clinical practice: colonization, fomites, and virulence: rethinking the pathogenesis of community-associated methicillin-resistant Staphylococcus aureus infection.
    Clin Infect Dis, 46(5): 752-60. [Abstract] [Full-text]
18. Postoperatively administered vancomycin reaches therapeutic concentration in the cerebral spinal fluid of neurosurgical patients.
    Surg Neurol, 69(2): 126-9; discussion 129. [Abstract] [Full-text]
19. Relationships between vancomycin pharmacodynamics and the emergence of vancomycin-intermediate Staphylococcus aureus (VISA) from heterogeneous VISA in an in vitro pharmacodynamic model.
    J Antimicrob Chemother. [Abstract] [Full-text]
20. Epidemiology, clinical manifestations, and treatment options for skin and soft tissue infection caused by community-acquired methicillin-resistant Staphylococcus aureus.
    J Am Acad Nurse Pract, 20(2): 85-92. [Abstract] [Full-text]
21. Comparison of SSI Rates in Endoarthroplasty of Hip and Knee in a Cracow Patient Population and the Importance of Postdischarge Surveillance.
    Infection, 36(1): 36-40. [Abstract] [Full-text]
22. Prostatic Abscess Due to Community-Acquired Methicillin-Resistant Staphylococcus aureus.
    Am J Med Sci, 335(2): 154-6. [Abstract] [Full-text]
23. Development and validation of microarray-based assay for epidemiological study of MRSA.
    Mol Cell Probes, 22(1): 1-13. [Abstract] [Full-text]
24. Evaluation of the in vitro activity of tigecycline against multiresistant Gram-positive cocci containing tetracycline resistance determinants.
    Int J Antimicrob Agents, 31(3): 209-15. [Abstract] [Full-text]
25. VARIABILITY AMONG PEDIATRIC INFECTIOUS DISEASES SPECIALISTS IN THE TREATMENT AND PREVENTION OF METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS SKIN AND SOFT TISSUE INFECTIONS.
    Pediatr Infect Dis J. [Abstract] [Full-text]
26. Epidemiology of diabetic foot problems and predictive factors for limb loss.
    J Diabetes Complications, 22(2): 77-82. [Abstract] [Full-text]
27. Visual outcome and bacterial sensitivity after methicillin-resistant Staphylococcus aureus-associated acute endophthalmitis.
    Am J Ophthalmol, 145(3): 413-417. [Abstract] [Full-text]
28. Subinhibitory concentrations of telithromycin, clarithromycin and azithromycin reduce methicillin-resistant Staphylococcus aureus coagulase in vitro and in vivo.
    J Antimicrob Chemother, 61(3): 647-50. [Abstract] [Full-text]
29. Frequency of biocide resistance genes, antibiotic resistance and the effect of chlorhexidine exposure on clinical methicillin-resistant Staphylococcus aureus isolates.
    J Antimicrob Chemother, 61(3): 524-32. [Abstract] [Full-text]
30. Increased US emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, during the emergence of community-associated methicillin-resistant Staphylococcus aureus.
    Ann Emerg Med, 51(3): 291-8. [Abstract] [Full-text]
31. In vitro activity profile of ceftobiprole, an anti-MRSA cephalosporin, against recent gram-positive and gram-negative isolates of European origin.
    J Antimicrob Chemother, 61(3): 595-602. [Abstract] [Full-text]
32. An antidote for Staphylococcus aureus pneumonia?
    J Exp Med, 205(2): 271-4. [Abstract] [Full-text]
33. Vaccine protection against Staphylococcus aureus pneumonia.
    J Exp Med, 205(2): 287-94. [Abstract] [Full-text]
34. Nosocomial Infections Due to Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococcus: Relationships with Antibiotic Use and Cost Drivers (March).
    Ann Pharmacother. [Abstract] [Full-text]
35. Fatal necrotizing pneumonia due to a Panton-Valentine leukocidin positive community-associated methicillin-sensitive Staphylococcus aureus and Influenza co-infection: a case report.
    Ann Clin Microbiol Antimicrob, 7(1): 5. [Abstract] [Full-text]
36. Impact of rapid molecular screening for meticillin-resistant Staphylococcus aureus in surgical wards.
    Br J Surg, 95(3): 381-6. [Abstract] [Full-text]
37. Are community-associated methicillin-resistant Staphylococcus aureus (MRSA) strains replacing traditional nosocomial MRSA strains?
    Clin Infect Dis, 46(6): 787-94. [Abstract] [Full-text]
38. Comparison of both clinical features and mortality risk associated with bacteremia due to community-acquired methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus.
    Clin Infect Dis, 46(6): 799-806. [Abstract] [Full-text]
39. Validation of a Virulence and Epidemiology (VirEp) DNA microarray for Staphylococcus aureus.
    J Clin Microbiol. [Abstract] [Full-text]
40. A new microbiological problem in intensive care units: Environmental contamination by MRSA with reduced susceptibility to glycopeptides.
    Int J Hyg Environ Health, 211(1): 213-8. [Abstract] [Full-text]
41. Evidence for cost reduction based on pre-admission MRSA screening in general surgery.
    Int J Hyg Environ Health, 211(1): 205-212. [Abstract] [Full-text]
42. Daptomycin: a new treatment for insidious infections due to gram-positive pathogens.
    Swiss Med Wkly, 138(7): 93-9. [Abstract] [Full-text]
43. Is MRSA admission bacteraemia community-acquired? A case control study.
    J Infect, 56(3): 163-70. [Abstract] [Full-text]
44. Prophylactic antibiotics given within 24 hours of surgery, compared with antibiotics given for 72 hours perioperatively, increased the rate of methicillin-resistant Staphylococcus aureus isolated from surgical site infections.
    J Infect Chemother, 14(1): 44-50. [Abstract] [Full-text]
45. The antagonistic effects of a combination of vancomycin and minocycline in Staphylococcus aureus with heterogeneous resistance to vancomycin.
    J Infect Chemother, 14(1): 15-22. [Abstract] [Full-text]
46. Novel characteristics of community-acquired methicillin-resistant Staphylococcus aureus strains belonging to multilocus sequence type 59 in Taiwan.
    Antimicrob Agents Chemother, 52(3): 837-45. [Abstract] [Full-text]
47. Antimicrobial activities of Ceftaroline and ME1036 tested against clinical strains of community-acquired methicillin-resistant Staphylococcus aureus.
    Antimicrob Agents Chemother, 52(3): 1153-5. [Abstract] [Full-text]
48. Community-acquired methicillin-resistant Staphylococcus aureus: an emerging concern for physical therapists: Discussion.
    Physiother Res Int, 13(1): 9-17. [Abstract] [Full-text]

© 2004-2012 MRSA Research Today. All Rights Reserved.